IIIVHIGH SIGNALFINANCIAL10-K

IIIV completed major business divestitures while achieving operational turnaround from $4.8M operating loss to $3.8M profit, but experienced severe cash flow deterioration dropping 88% to $5.7M.

The company successfully executed a strategic restructuring by divesting two business units (Merchant Services and Healthcare RCM) while dramatically improving operational efficiency through 35% SG&A reduction. However, the precipitous decline in operating cash flow despite improved profitability raises concerns about cash generation sustainability and working capital management post-divestiture.

Comparing 2025-11-21 vs 2024-11-25View on EDGAR →
FINANCIAL ANALYSIS

IIIV demonstrated strong operational improvement with gross profit growing 18% to $333M and achieving an operational turnaround from -$4.8M to +$3.8M operating income through aggressive cost cutting that reduced SG&A by 35%. The divestiture activities significantly cleaned up the balance sheet, reducing total liabilities by 44% and current liabilities by 57%, while total assets declined 13% reflecting the sold business units. However, the dramatic 88% collapse in operating cash flow to just $5.7M despite improved profitability signals potential working capital issues or one-time impacts that investors should monitor closely.

FINANCIAL STATEMENT CHANGES
Operating Income
P&L
+178.5%
-$4.8M$3.8M

Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.

Operating Cash Flow
Cash Flow
-88.2%
$48.4M$5.7M

Operating cash flow fell 88.2% — earnings quality concerns; investigate working capital changes and non-cash items.

Current Liabilities
Balance Sheet
-57.1%
$164.7M$70.7M

Current liabilities reduced — improved short-term financial position and working capital health.

Total Liabilities
Balance Sheet
-43.9%
$215.3M$120.7M

Liabilities reduced 43.9% — deleveraging improves balance sheet strength and financial flexibility.

Net Income
P&L
+38.7%
$12.9M$17.9M

Net income grew 38.7% — bottom-line growth signals improving overall business health.

SG&A Expense
P&L
-35%
$176.4M$114.7M

SG&A reduced 35% — improved cost efficiency or headcount reduction improving operating margins.

Capital Expenditure
Cash Flow
-34.5%
$3.0M$1.9M

Capex reduced 34.5% — investment cycle winding down or capital discipline; may improve near-term free cash flow.

Cash & Equivalents
Balance Sheet
-23%
$86.5M$66.7M

Cash decreased 23% — monitor burn rate and upcoming capital needs.

Gross Profit
P&L
+17.9%
$282.7M$333.3M

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Total Assets
Balance Sheet
-12.6%
$730.7M$638.4M

Total assets contracted 12.6% — asset sales, write-downs, or balance sheet optimization underway.

LANGUAGE CHANGES
NEW — 2025-11-21
PRIOR — 2024-11-25
ADDED
As of November 20, 2025, there were 23,972,102 outstanding shares of Class A common stock, $0.0001 par value per share, and 8,381,681 outstanding shares of Class B common stock, $0.0001 par value per share.
Management's Discussion and Analysis of Financial Condition and Results of Operations 50 Item 7A.
We are subject to risks associated with general economic and geopolitical conditions, the business cycles of our customers, and changes in the overall level of consumer and commercial spending, which could negatively impact our business, financial condition and results of operations.
There are certain risks associated with the sale of our Merchant Services Business which was completed in September 2024 and the sale of our Healthcare RCM Business which was completed in May 2025.
The evolving legal, ethical, and regulatory landscape over AI technologies creates uncertainties.
+7 more — sign up free →
REMOVED
As of November 22, 2024, there were 23,507,730 outstanding shares of Class A common stock, $0.0001 par value per share, and 10,032,676 outstanding shares of Class B common stock, $0.0001 par value per share.
Management's Discussion and Analysis of Financial Condition and Results of Operations 56 Item 7A.
We are subject to economic and political risk, the business cycles of our customers and changes in the overall level of consumer and commercial spending, which could negatively impact our business, financial condition and results of operations.
Rapidly evolving domestic and global conditions are beyond our control and could materially adversely affect our business, operations and results of operations.
Actual or perceived failures to comply with applicable healthcare laws and regulations could result in a material breach of contract with one or more of our customers in our Healthcare vertical, harm our reputation and subject us to substantial civil and criminal penalties.
+7 more — sign up free →
MORE FINANCIAL SIGNALS
PNRGHIGHPNRG achieved exceptional profitability improvement with net income surging 2,21...
2026-04-16
BNAIHIGHBNAI underwent a dramatic reverse stock split that reduced share count by 86% wh...
2026-04-16
LAKEHIGHLAKE's financial performance deteriorated significantly with operating losses wo...
2026-04-16
NXXTHIGHNextNRG experienced massive financial deterioration with operating losses explod...
2026-04-16
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →